LIFE TECHNOLOGIES CORPORATION, et al., Petitioners v. PROMEGA CORPORATION, 580 U.S. 140

Summary

HOLDINGS: [1]-The U.S. Court of Appeals for the Federal Circuit erred when it found that a company that obtained a license under U.S. Patent No. RE 37,984 so it could manufacture and sell genetic testing kits for use in certain licensed law enforcement fields worldwide committed patent infringement under 35 U.S.C.S. § 271(f)(1) when it sold its kits outside the licensed fields of use because it manufactured one of the components of its kits in the United States and shipped that component to the United Kingdom where it was combined with four other components that were used in each kit; [2]-The phrase “a substantial portion” that was used in § 271(f)(1) had a quantitative, not a qualitative, meaning, and § 271(f)(1) did not cover the supply of a single component of a multicomponent invention.